ClinicalTrials.govpublic full text
Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure
coronavirus infection, severe acute respiratory syndrome coronavirus 2 (sars-cov-2), covid-19 disease, dna vaccine, electroporation, healthy, covid-19, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 892368
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.